Front. Oncol.
Frontiers in Oncology
Front. Oncol.
2234-943X
Frontiers Media S.A.
10.3389/fonc.2023.1302993
Oncology
Correction
Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
Mosquera OrgueiraAdrián
1
*
†
Peleteiro RaíndoAndrés
1
†
Díaz AriasJosé Ángel
1
Antelo RodríguezBeatriz
1
López RiñónMónica
2
CerchioneClaudio
3
de la Fuente BurgueraAdolfo
4
González PérezMarta Sonia
1
MartinelliGiovanni
3
Montesinos FernándezPau
5
Pérez EncinasManuel Mateo
1
1Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
2Department of Hematology, Tomelloso Hospital, Ciudad Real, Spain
3Unit of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
4Department of Hematology, MD Anderson Cancer Center, Madrid, Spain
5Department of Hematology, Hospital La Fe, Valencia, Spain
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Adrián Mosquera Orgueira, adrian.mosquera.orgeira@sergas.es
†These authors have contributed equally to this work and share first authorship
04
10
2023
2023
13
1302993
27
09
2023
28
09
2023
Copyright © 2023 Mosquera Orgueira, Peleteiro Raíndo, Díaz Arias, Antelo Rodríguez, López Riñón, Cerchione, de la Fuente Burguera, González Pérez, Martinelli, Montesinos Fernández and Pérez Encinas
2023
Mosquera Orgueira, Peleteiro Raíndo, Díaz Arias, Antelo Rodríguez, López Riñón, Cerchione, de la Fuente Burguera, González Pérez, Martinelli, Montesinos Fernández and Pérez Encinas
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A corrigendum on Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia by Mosquera Orgueira A, Peleteiro Raíndo A, Díaz Arias JÁ, Antelo Rodríguez B, López Riñón M, Cerchione C, de la Fuente Burguera A, González Pérez MS, Martinelli G, Montesinos Fernández P and Pérez Encinas MM (2022) Front. Oncol. 12:968340. doi: 10.3389/fonc.2022.968340
leukemia
transcriptome
machine learning
survival
risk
prediction
section-in-acceptance
Hematologic Malignancies
In the published article, there was an error in affiliations 3 and 4. Instead of “3Department of Hematology, MD Anderson Cancer Center, Madrid, Spain, 4Unit of Hematology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Istituto Tumori della Romagna IRST IRCCS, Meldola, Italy”, it should be “3Unit of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, 4Department of Hematology, MD Anderson Cancer Center, Madrid, Spain”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.